Hypericin as a Photodynamic Immunomodulator: A Natural Compound for Dermatological Therapy
Abstract
Hypericin, a polycyclic quinone derived from *Hypericum perforatum* (St. John's Wort), has gained attention for its broad pharmacological activities, including anti-inflammatory, antimicrobial, and antitumor effects. It modulates key signaling pathways like NF-κB and MAPK, reducing chronic inflammation and making it effective in treating autoimmune and infectious skin conditions. As a photosensitizer, hypericin also induces apoptosis in abnormal cells through photodynamic therapy (PDT), showing promising results in treating cutaneous T-cell lymphoma (CTCL), psoriasis, and fungal infections. While its solubility and bioavailability remain challenges, hypericin's favorable safety profile and therapeutic potential position it as a valuable option for managing refractory dermatological conditions.
Fields of Study & Subjects
Natural Compound Pharmacology Studies
Photodynamic Therapy Research Studies
Beetle Biology and Toxicology Studies
Publication details
- Journal / source
- Drug Design Development and Therapy
- Publisher
- Informa UK Limited
- Volume
- Volume 20
- Pages
- 1–21
- Publication date
- 1 January 2026
- Language
- EN